Aayush Wellness Limited, an integrated healthcare company dedicated to holistic wellness and innovation, is pleased to announce that its Board of Directors has approved the formation of a wholly owned subsidiary in Singapore with an initial capital investment of SG$ 10,000.

This strategic expansion marks a significant step in the company's global growth strategy and will serve as a launchpad for its nutraceutical and healthcare products across the rapidly expanding Southeast Asian markets.

Naveena Kumar, Managing Director of Aayush Wellness said "Our new Singapore-based subsidiary will enable us to tap into one of the world's most dynamic wellness markets, offering greater agility in operations, regulatory efficiency, and direct access to high-growth ASEAN economies. This is a critical step toward building a global wellness brand."

The Southeast Asian nutraceutical market is projected to reach US$ 15.1 billion by 2028, growing at a CAGR of 7.5%, driven by rising health consciousness, urbanization, and preference for preventive healthcare solutions.

This development is in line with Aayush Wellness Limited's broader mission to deliver science-backed, sustainable, and natural healthcare solutions globally. The company aims to use its new presence in Singapore to not only access markets in Malaysia, Indonesia, Thailand, and Vietnam, but also to establish a foundation for future global partnerships and innovation.